Alternative Data for Zoetis
About Zoetis
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and precision livestock farming.
| Price | $127.42 |
| Target Price | Sign up |
| Volume | 4,130,000 |
| Market Cap | $56.5B |
| Year Range | $115.25 - $168.42 |
| Dividend Yield | 1.52% |
| PE Ratio | 21.45 |
| Analyst Rating | 89% buy |
| Earnings Date | February 12 '26 |
| Industry | Pet Care |
In the news
Pelican Bay Capital Management Bets on Zoetis (ZTS) to Capitalize on Expanding Pet Care MarketFebruary 6 - Yahoo Entertainment |
|
 |
Zoetis (ZTS) Valuation Check As 2026 Outlook Is Tempered On Softer Pet Visits And Regulatory ScrutinyFebruary 5 - Yahoo |
|
Zoetis Declares Second Quarter 2026 DividendFebruary 5 - Yahoo |
|
Do Wall Street Analysts Like Zoetis Stock?February 5 - Yahoo |
|
Zoetis (ZTS) Expected to Beat Earnings Estimates: Should You Buy?February 4 - Yahoo |
|
Zoetis Inc. (ZTS): A Bull Case TheoryFebruary 4 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 2.4B | 683M | 1.72B | 721M | 1.07B | 1.700 |
| Q2 '25 | 2.46B | 682M | 1.78B | 718M | 1.08B | 1.610 |
| Q1 '25 | 2.22B | 654M | 1.57B | 631M | 988M | 1.480 |
| Q4 '24 | 2.32B | 741M | 1.58B | 581M | 911M | 1.400 |
| Q3 '24 | 2.39B | 736M | 1.65B | 682M | 1.06B | 1.580 |
Insider Transactions View All
| Lagano Roxanne filed to sell 15,129 shares at $170. June 4 '25 |
| Reed Willie M filed to sell 11,245 shares at $166.1. March 11 '25 |
| Lagano Roxanne filed to sell 15,781 shares at $170. March 11 '25 |
| PECK KRISTIN C filed to sell 94,194 shares at $156.7. February 20 '25 |
| Lagano Roxanne filed to sell 16,107 shares at $171.2. February 11 '25 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Ro Khanna |
Nov 14, 25 | Buy | $1K - $15K |
| Rick Larsen |
Oct 17, 25 | Sell | $1K - $15K |
| Lisa McClain |
Aug 13, 25 | Buy | $1K - $15K |
Read more about Zoetis (ZTS) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, app downloads, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Zoetis
The Market Cap of Zoetis is $56.5B.
As of today, Zoetis' PE (Price to Earnings) ratio is 21.45.
Zoetis will report its next earnings on February 12 '26.
Currently, the price of one share of Zoetis stock is $127.42.
The ZTS stock price chart above provides a comprehensive visual representation of Zoetis' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Zoetis shares. Our platform offers an up-to-date ZTS stock price chart, along with technical data analysis and alternative data insights.
Yes, Zoetis (ZTS) offers dividends to its shareholders, with a dividend yield of 1.52%. This dividend yield represents Zoetis' commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Zoetis in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
Some of the similar stocks of Zoetis are Chewy, Petco, PetMeds, BARK, and Chewy.
